Pfizer eyes cost cuts on volatile Covid products demand
Pfizer will launch a cost-cutting programme if demand for its Covid-19 products keeps underperforming expectations this fall, the US drugmaker said today, after quarterly sales for the vaccine and pill fell short of Wall Street targets.
Business
• 02 Aug 23
